-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Gilead Sciences, Raises Price Target to $181

Benzinga·10/30/2026 16:36:48
语音播报
Truist Securities analyst Gregory Renza maintains Gilead Sciences (NASDAQ:GILD) with a Buy and raises the price target from $158 to $181.